Clinical Trial Update: PATHWAYS--FULL SCALE STUDY [Phase 2]

View source ↗

Summary

PATHWAYS full-scale Phase 2 clinical trial has completed, with the study focusing on cardiovascular disease and obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Obesity

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Sedentary Behaviors | Phase 2 | Status: COMPLETED